Skip to main content
. 2019 Nov 25;11(6):943–953. doi: 10.1111/os.12547

Table 3.

The results of subgroup analysis

Outcomes Subgroups Effect estimate
Studies χ2 MD and 95% CI I 2 (%) P
VAS at POD0 CFNB 2 0.07 0.42(−0.02,0.86) 0 0.8
SFNB 4 35.91 0.03(−0.73,0.78) 92 <0.00001
VAS at POD1 CFNB 2 0.17 0.49(0.09,0.9) 0 0.68
SFNB 3 23.53 '‐0.48(−1.54,0.59) 91 <0.00001
Total morphine CFNB 2 0.01 −70.97(−104.11, −37.83) 0 0.93
SFNB 4 535.92 −36.51(−82.86,9.83) 99 <0.00001
LOS CFNB 4 1.85 −0.36(−0.53,−0.19) 0 0.6
SFNB 5 11.82 −0.22(−0.41,−0.03) 66 0.02